Glucose uptake and distribution across the human skeleton using state-of-the-art total-body PET/CT

Abstract

A growing number of studies have demonstrated that the skeleton is an endocrine organ that is involved in glucose metabolism and plays a significant role in human glucose homeostasis. However, there is still a limited understanding of the in vivo glucose uptake and distribution across the human skeleton. To address this issue, we aimed to elucidate the detailed profile of glucose uptake across the skeleton using a total-body positron emission tomography (PET) scanner. A total of 41 healthy participants were recruited. Two of them received a 1-hour dynamic total-body ¹⁸F-fluorodeoxyglucose (¹⁸F-FDG) PET scan, and all of them received a 10-minute static total-body ¹⁸F-FDG PET scan. The net influx rate (K_i) and standardized uptake value normalized by lean body mass (SUL) were calculated as indicators of glucose uptake from the dynamic and static PET data, respectively. The results showed that the vertebrae, hip bone and skull had relatively high K_i and SUL values compared with metabolic organs such as the liver. Both the K_i and SUL were higher in the epiphyseal, metaphyseal and cortical regions of long bones. Moreover, trends associated with age and overweight with glucose uptake (SUL_max and SUL_mean) in bones were uncovered. Overall, these results indicate that the skeleton is a site with significant glucose uptake, and skeletal glucose uptake can be affected by age and dysregulated metabolism.

References

[1] Karner CM, Long F. Glucose metabolism in bone. Bone., 2018, 115: 2-7

[2] Long F. Energy Metabolism and Bone. Bone., 2018, 115: 1

[3] Zhang Q, Riddle RC, Clemens TL. Bone and the regulation of global energy balance. J. Intern. Med., 2015, 277: 681-689

[4] Cipriani C et al. The Interplay Between Bone and Glucose Metabolism. Front. Endocrinol. (Lausanne), 2020, 11: 122

[5] Riddle RC, Clemens TL. Bone Cell Bioenergetics and Skeletal Energy Homeostasis. Physiol. Rev., 2017, 97: 667-698

[6] Guntur AR, Rosen CJ. Bone as an endocrine organ. Endocr. Pract., 2012, 18: 758-762

[7] Zoch ML, Clemens TL, Riddle RC. New insights into the biology of osteocalcin. Bone., 2016, 82: 42-49

[8] Karsenty G, Ferron M. The contribution of bone to whole-organism physiology. Nature., 2012, 481: 314-320

[9] Li X et al. Osteoclasts May Affect Glucose Uptake-Related Insulin Resistance by Secreting Resistin. Diabetes Metab. Syndr. Obes., 2021, 14: 3461-3470

[10] Zhang L et al. Spectral tracing of deuterium for imaging glucose metabolism. Nat. Biomed. Eng., 2019, 3: 402-413

[11] Sprinz C et al. Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review. PLoS One, 2018, 13: e0193140

[12] Zoch ML, Abou DS, Clemens TL, Thorek DL, Riddle RC. In vivo radiometric analysis of glucose uptake and distribution in mouse bone. Bone Res., 2016, 4: 16004

[13] Lu, W. et al. An atlas of glucose uptake across the entire human body as measured by the total-body PET/CT scanner: A pilot study, Life Metabolism, 2022 [Epub ahead of print].

[14] Vandenberghe S, Moskal P, Karp JS. State of the art in total body PET. EJNMMI Phys., 2020, 7

[15] Zhang X et al. Subsecond total-body imaging using ultrasensitive positron emission tomography. Proc. Natl. Acad. Sci. USA, 2020, 117: 2265-2267

[16] Spencer BA et al. Performance evaluation of the uEXPLORER Total-Body PET/CT scanner based on NEMA NU 2-2018 with additional tests to characterize PET scanners with a long axial field of view. J. Nucl. Med., 2021, 62: 861-870

[17] Wang G et al. Total-Body PET Multiparametric imaging of cancer using a voxelwise strategy of compartmental modeling. J. Nucl. Med., 2022, 63: 1274-1281

[18] Hume R. Prediction of lean body mass from height and weight. J. Clin. Pathol., 1966, 19: 389-391

[19] Doğru S, Deniz M, Uslu AI. Anthropometric Analysis of Nasolabial Region and Age-Related Changes in Adult Women. J. Craniofac. Surg., 2020, 31: 1161-1165

[20] Rotella F et al. Comparison between normal-weight and overweight bulimic patients. Eat. Weight. Disord., 2013, 18: 389-393

[21] Donat A et al. Glucose metabolism in osteoblasts in healthy and pathophysiological conditions. Int. J. Mol. Sci., 2021, 22: 4120

[22] Han Y, You X, Xing W, Zhang Z, Zou W. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts. Bone Res., 2018, 6: 16

[23] Karner CM, Long F. Wnt signaling and cellular metabolism in osteoblasts. Cell Mol. Life Sci., 2017, 74: 1649-1657

[24] Rathinavelu S, Guidry-Elizondo C, Banu J. Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 Diabetes. J. Diabetes Res., 2018, 2018: 6354787

[25] Bilotta FL et al. Insulin and osteocalcin: further evidence for a mutual cross-talk. Endocrine., 2018, 59: 622-632

[26] Wei J et al. Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation. Cell., 2015, 161: 1576-1591

[27] Burianova V, Kalinin S, Supuran CT, Krasavin M. Radiotracers for positron emission tomography (PET) targeting tumour-associated carbonic anhydrase isoforms. Eur. J. Med. Chem., 2021, 213: 113046

[28] Christensen NL et al. Whole-Body Biodistribution, Dosimetry, and Metabolite Correction of [11C]Palmitate: A PET Tracer for Imaging of Fatty Acid Metabolism. Mol. Imaging, 2017, 16: 1536012117734485

[29] Suchacki KJ et al. A systems-level analysis of total-body PET data reveals complex skeletal metabolism networks in vivo. Front. Med. (Lausanne), 2021, 8: 740615

[30] Yang J et al. PET Index of Bone Glucose Metabolism (PIBGM) Classification of PET/CT Data for fever of unknown origin diagnosis. PLoS One, 2015, 10: e0130173

[31] Chen Y, Zhou M, Liu J, Huang G. Prognostic value of bone marrow FDG uptake pattern of PET/CT in newly diagnosed diffuse large B-cell lymphoma. J. Cancer, 2018, 9: 1231-1238

[32] Dirckx N et al. Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism. J. Clin. Invest., 2018, 128: 1087-1105

[33] Greenhill C. Metabolism: Role of bone in glucose metabolism. Nat. Rev. Endocrinol., 2018, 14: 191

[34] Thomas DM, Hards DK, Rogers SD, Ng KW, Best JD. Insulin receptor expression in bone. J. Bone Miner. Res., 1996, 11: 1312-1320

[35] Al-Salam A, Irwin DM. Evolution of the vertebrate insulin receptor substrate (Irs) gene family. BMC Evol. Biol., 2017, 17: 148

[36] Huovinen V et al. Vertebral bone marrow glucose uptake is inversely associated with bone marrow fat in diabetic and healthy pigs: [(18)F]FDG-PET and MRI study. Bone., 2014, 61: 33-38

[37] Suchacki KJ et al. Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis. Nat. Commun., 2020, 11

[38] Huovinen V et al. Femoral bone marrow insulin sensitivity is increased by resistance training in elderly female offspring of overweight and obese mothers. PLoS One, 2016, 11: e0163723

[39] Thiel A et al. Osteoblast migration in vertebrate bone. Biol. Rev. Camb. Philos. Soc., 2018, 93: 350-363

[40] Shao J et al. Correlation between bone turnover and metabolic markers with age and gender: A cross-sectional study of hospital information system data. BMC Musculoskelet. Disord., 2020, 21

[41] Demontiero O, Vidal C, Duque G. Aging and bone loss: New insights for the clinician. Ther. Adv. Musculoskelet. Dis., 2012, 4: 61-76

[42] Wei Y, Sun Y. Aging of the Bone. Adv. Exp. Med. Biol., 2018, 1086: 189-197

[43] Becerikli M et al. Age-dependent alterations in osteoblast and osteoclast activity in human cancellous bone. J. Cell Mol. Med., 2017, 21: 2773-2781

[44] Hou J et al. Obesity and bone health: A complex link. Front. Cell Dev. Biol., 2020, 8: 600181

[45] Cao JJ. Effects of obesity on bone metabolism. J. Orthop. Surg. Res., 2011, 6: 30

Funding

Taishan Scholar Foundation of Shandong Province(TS201712065)

This work was supported by the Science and Technology Funding from Jinan (grant number: 2020GXRC018), Academic Promotion Program of Shandong First Medical University (grant number: 2019QL009), and Taishan Scholars Program of Shandong Province (grant number: TS201712065).